drugset

drugset / Trial / NCT00143338

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

NCT00143338 ↗

Phase 2 Completed 20 enrolled Pfizer Sanofi · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.

Timeline

Start: 2004-11
Primary completion: —
Completion: 2006-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Insulin	Protein / enzyme biologic	—	Inhaled

Indications